Literature DB >> 2514248

Follicle-stimulating hormones in anterior pituitary glands from children and adults differ in relation to sex and age.

L Wide1.   

Abstract

Follicle-stimulating hormone (FSH) in extracts of the anterior lobe of pituitaries, collected at autopsy from 13 boys, 21 girls, 17 men and 26 women, was measured in terms of biological activity (B) in vitro by the Sertoli cell aromatase bioassay, and in terms of immunological activity (I) by a radioimmunoassay. The highest concentration of FSH in the anterior lobe found by bioassay was in young girls, who had a mean value three to seven times higher than that in young and elderly men and women and nine times higher than that in young boys. The total amount of FSH in the pituitary found by bioassay and immunoassay was very much less in young boys than in all other groups. The B/I ratio of FSH was higher for all the 27 children below 10 years of age than for any of the 43 adults. This difference in B/I ratio of FSH in whole pituitary extracts persisted in fractions after electrophoretic separation. The mean B/I ratio for young girls was 1.26 times higher than that for young boys and 2.25 times higher than that for adults. Young and elderly men and women had almost identical B/I ratios. All extracts were analysed after electrophoresis and the median charge and charge homogeneity of FSH were estimated. The number of different forms of FSH in pituitary extracts from a child was at least 20-30, similar to that in an adult. In girls, the median charge of FSH was similar to that of young women and significantly less negative than in elderly women. The median charge of FSH in boys was more negative than in girls, but less negative than in both young and elderly men. After treatment of pituitary extracts with neuraminidase, the median charge of FSH in infants was significantly more negative than that in adults. This, together with the differences in B/I ratios between children and adults, indicates a change at puberty in the molecular structure of FSH from juvenile to adult forms of the hormone.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2514248     DOI: 10.1677/joe.0.1230519

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  7 in total

1.  Efficacy of a combined protocol of urinary and recombinant follicle-stimulating hormone used for ovarian stimulation of patients undergoing ICSI cycle.

Authors:  Arianna Pacchiarotti; Cesare Aragona; Renzo Gaglione; Helmy Selman
Journal:  J Assist Reprod Genet       Date:  2007-07-26       Impact factor: 3.412

Review 2.  In vitro bioassays of follicle-stimulating hormone: methods and clinical applications.

Authors:  M Simoni; E Nieschlag
Journal:  J Endocrinol Invest       Date:  1991-12       Impact factor: 4.256

3.  LH isoform profiles during short-term pulsatile LHRH administration in elderly men.

Authors:  M Giusti; S Valenti; R Guido; C M Cuttica; L Foppiani; G Giordano
Journal:  J Endocrinol Invest       Date:  1997-04       Impact factor: 4.256

Review 4.  Follicle-Stimulating Hormone Glycobiology.

Authors:  George R Bousfield; David J Harvey
Journal:  Endocrinology       Date:  2019-06-01       Impact factor: 4.736

5.  Myo-inositol therapy for poor-responders during IVF: a prospective controlled observational trial.

Authors:  Francesca Caprio; Maria Diletta D'Eufemia; Carlo Trotta; Maria Rosaria Campitiello; Raffaele Ianniello; Daniela Mele; Nicola Colacurci
Journal:  J Ovarian Res       Date:  2015-06-12       Impact factor: 4.234

6.  Basal and gonadotropin-releasing hormone-releasable serum follicle-stimulating hormone charge isoform distribution and in vitro biological-to-immunological ratio in male puberty.

Authors:  A Olivares; D Söderlund; C Castro-Fernández; T Zariñán; Elena Zambrano; J P Méndez; A Ulloa-Aguirre
Journal:  Endocrine       Date:  2004 Mar-Apr       Impact factor: 3.925

7.  Low-glycosylated forms of both FSH and LH play major roles in the natural ovarian stimulation.

Authors:  Leif Wide; Karin Eriksson
Journal:  Ups J Med Sci       Date:  2018-06-12       Impact factor: 2.384

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.